GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Sep 2016 07:00 AM
RNS
Positive Results from the COPD Salford Lung Study
01 Sep 2016 02:42 PM
RNS
Total Voting Rights
30 Aug 2016 12:36 PM
RNS
Director/PDMR Shareholding
23 Aug 2016 03:45 PM
RNS
Director/PDMR Shareholding
16 Aug 2016 03:07 PM
RNS
Director/PDMR Shareholding
16 Aug 2016 01:07 PM
RNS
ViiV starts PhIII Programme for dolutegravir & 3TC
12 Aug 2016 04:08 PM
RNS
Director/PDMR Shareholding
10 Aug 2016 02:45 PM
RNS
Director/PDMR Shareholding
09 Aug 2016 05:43 PM
RNS
Director/PDMR Shareholding
04 Aug 2016 03:49 PM
RNS
Publication of a Prospectus
01 Aug 2016 03:26 PM
RNS
Director/PDMR Shareholding
01 Aug 2016 12:11 PM
RNS
Total Voting Rights
01 Aug 2016 07:00 AM
RNS
GSK and Verily to establish Galvani Bioelectronics
28 Jul 2016 06:22 PM
RNS
Director/PDMR Shareholding
27 Jul 2016 12:01 PM
RNS
Half-year Report
25 Jul 2016 03:29 PM
RNS
Director/PDMR Shareholding
20 Jul 2016 05:15 PM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
20 Jul 2016 07:00 AM
RNS
Director/PDMR Shareholding
19 Jul 2016 06:31 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 06:28 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 06:25 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 06:21 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:57 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:54 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:50 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:45 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:39 PM
RNS
Director/PDMR Shareholding
19 Jul 2016 05:33 PM
RNS
Director/PDMR Shareholding
18 Jul 2016 05:05 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings